Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tell

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
The British Journal of Dermatology|July 23, 2017
KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomasD Dias-Santagata, M A Selim, Y Su, et al.
Vaccines|September 23, 2022
Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP <i>Zaire ebolavirus</i> Vaccine to Inform Marburg Virus and <i>Sudan ebolavirus</i> VaccinesBeth-Ann G Coller, William Lapps, Mahum Yunus, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
The British Journal of Dermatology|July 23, 2017
KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomasD Dias-Santagata, M A Selim, Y Su, et al.
Vaccines|September 23, 2022
Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP <i>Zaire ebolavirus</i> Vaccine to Inform Marburg Virus and <i>Sudan ebolavirus</i> VaccinesBeth-Ann G Coller, William Lapps, Mahum Yunus, et al.
Pageof 9